ArticleCrohn's & colitis 3602024

Clinical Trial Design in Ulcerative Colitis: Interpreting Evolving Endpoints Based on Post Hoc Analyses of the Vedolizumab Phase 3 Trials GEMINI 1 and VISIBLE 1.

William J Sandborn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.